Phable,India’s largest Chronic Disease Management App, unveiled insights from their recent clinical studies conducted for Hypertension and Type 2 Diabetes at the BPCON Conference 2022 - Annual Meeting of Indian Society of Hypertension, Lucknow and at the RSSDI Conference 2022 - Annual Meeting of Research Society of the Study of Diabetes in India, Chennai.
Digital Therapeutics
The studies established that digital therapeutics (DTx) intervention, applied through Phable's proprietary algorithm and smartphone devices, helped chronic disease patients regain control of their health. Technology-driven behavior changes powered by Phable's algorithm and applied through a smartphone can be the constant companion that chronic disease patients need. Using smartphones, wearables, and monitoring devices, patients can self-monitor their health parameters and report them to the Phable app.
Phable’s proprietary algorithm takes in the health signals and suggests suitable actions to help drive behaviour change and treatment adherence in patients. Chronic disease patients can take control of their health with Phable, which is supported by the expertise of 17,000 doctors and the experience of helping 4.5 million Indians on their health journey, according to a communication from the organization.